diazoxide has been researched along with Chondrodystrophic Myotonia in 2 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Newfield, RS | 1 |
| Henn, MC | 1 |
| Janjua, MB | 1 |
| Zhang, H | 1 |
| Kanter, EM | 1 |
| Makepeace, CM | 1 |
| Schuessler, RB | 1 |
| Nichols, CG | 1 |
| Lawton, JS | 1 |
2 other studies available for diazoxide and Chondrodystrophic Myotonia
| Article | Year |
|---|---|
Topical sulfonylurea as a novel therapy for hypertrichosis secondary to diazoxide, and potentially for other conditions with excess hair growth.
Topics: Administration, Topical; Cardiomegaly; Diazoxide; Hair; Humans; Hypertrichosis; Mutation; Osteochond | 2015 |
Increased tolerance to stress in cardiac expressed gain-of-function of adenosine triphosphate-sensitive potassium channel subunit Kir6.1.
Topics: Animals; Cardiomegaly; Cell Size; Diazoxide; Genetic Markers; Hypertrichosis; KATP Channels; Mice; M | 2016 |